Director, Regulatory Affairs CMC

At Neurogene, we focus on bringing life‑changing genetic medicines to patients and families affected by rare, devastating neurological diseases. Our clinical‑stage company is developing NGN‑401 for the treatment of Rett syndrome. We are using our proprietary EXACT transgene regulation technology and internal expertise to develop novel approaches and treatments to address the limitations of conventional gene therapy in central nervous system disorders.

Our wholly owned and fully operational GMP‑capable manufacturing facility supports vector production from research through clinical grade and is designed for commercial‑grade production. In addition, Neurogene is now trading on the NASDAQ Global Market. This transformative work is driven by our highly collaborative people and comes together to bring us closer to achieving our mission of turning devastating diseases into treatable conditions, to improve the lives of patients and their families.

As an employee of Neurogene, you will be part of building a culture that honors patient and caregiver mindsets and nurtures innovation, creative problem solving and a strong sense of purpose.

We are seeking a Director, Regulatory Affairs CMC, to join the Regulatory Affairs CMC team to support a novel rare disease CNS pipeline. The individual will be part of a team that will provide support to the Regulatory Affairs (CMC) Team and the CMC/Manufacturing Teams at our gene therapy manufacturing facility in Houston to develop, plan, and execute the regulatory strategy to facilitate the achievement of the company’s short and long‑term objectives.

This individual will be a team player with roll‑up‑sleeve approach, can‑do attitude and functional subject matter expertise in CMC. This role will be an integral part of the transformative shift the company is making from the clinical development stage to commercialization.

• Provide CMC regulatory input to cross‑functional teams, including Technical Operations, Process Development, Quality, and Clinical Development.
• Contribute to global regulatory development plans and participate in CMC strategy discussions at project governance meetings.
• Partner with Process Development, Analytical Development, Quality, and Manufacturing teams to align regulatory strategies with technical and operational objectives in compliance with all applicable regulations and guidance.
• Anticipate and proactively identify regulatory risks, supporting mitigation strategies and recommendations.
• Support cross‑functional problem‑solving and contribute to decision‑making on complex regulatory and CMC development challenges.
• Ensure compliance with applicable laws, regulations, and guidelines by monitoring and interpreting the regulatory landscape, evolving guidance, and external trends relevant to gene therapy.
• Lead preparation, review, and submission of CMC components of INDs, CTAs, BLAs, MAAs, and related amendments/supplements for gene therapy products in accordance with global regulatory requirements.
• Support responses to health authority questions, preparation of briefing packages, and interactions with regulators on CMC matters, including preparation of internal teams for these engagements.
• Collaborate with clinical regulatory colleagues to ensure cohesive and compliant submissions across all modules.
• Support the development and maintenance of Regulatory Affairs programs, policies, and procedures.

• Bachelor’s degree in life sciences or a related field required
• Advanced degree (Ph.D., M.S., or equivalent) in Molecular Biology, Biochemistry, Pharmaceutical Sciences, or a related discipline preferred

• 10+ years of experience in Regulatory Affairs CMC
• 5 years focused on gene therapy, viral vectors, or biologics
• Proven success in developing and executing global regulatory CMC strategies for advanced therapy medicinal products (ATMPs) or biologics
• Strong track record of leading CMC submissions (IND/CTA through BLA/MAA) for gene therapy or biologics
• In‑depth understanding of biologics manufacturing, characterization, control strategies, and analytical…